Jeff Yass’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.08M Buy
154,663
+119,315
+338% +$2.55M ﹤0.01% 5365
2026
Q2
$1.02M Sell
35,348
-147,016
-81% -$3.97M ﹤0.01% 8143
2026
Q1
$3.3M Buy
182,364
+29,089
+19% +$555K ﹤0.01% 5072
2025
Q4
$3.33M Sell
153,275
-74,233
-33% -$2.13M ﹤0.01% 4690
2025
Q3
$7.42M Sell
227,508
-18,638
-8% -$688K ﹤0.01% 3460
2025
Q2
$8.74M Buy
246,146
+146,947
+148% +$4.76M ﹤0.01% 3016
2025
Q1
$3.37M Buy
99,199
+15,760
+19% +$565K ﹤0.01% 4417
2024
Q4
$2.72M Buy
83,439
+30,008
+56% +$1.24M ﹤0.01% 4661
2024
Q3
$2.6M Sell
53,431
-5,642
-10% -$301K ﹤0.01% 4799
2024
Q2
$2.62M Buy
+59,073
New +$2.73M ﹤0.01% 4569
2024
Q1
– Sell
-33,709
Closed -$2.03M – 12816
2023
Q4
$2.03M Buy
33,709
+20,135
+148% +$1.28M ﹤0.01% 5321
2023
Q3
$912K Buy
13,574
+5,748
+73% +$399K ﹤0.01% 6833
2023
Q2
$540K Buy
+7,826
New +$511K ﹤0.01% 8129
2023
Q1
– Sell
-55,532
Closed -$2.72M – 13091
2022
Q4
$2.77M Buy
+55,532
New +$2.69M ﹤0.01% 4139
2022
Q2
– Sell
-25,930
Closed -$1.09M – 13482
2022
Q1
$942K Sell
25,930
-6,717
-21% -$265K ﹤0.01% 7282
2021
Q4
$1.52M Buy
+32,647
New +$1.66M ﹤0.01% 6173
2021
Q3
– Sell
-56,309
Closed -$2.34M – 13197
2021
Q2
$2.31M Buy
56,309
+48,823
+652% +$1.66M ﹤0.01% 5598
2021
Q1
$217K Buy
+7,486
New +$204K ﹤0.01% 11265

Other funds holding LEGN

Jeff Yass's LEGN Position: Q3 2026 in Review

Jeff Yass increased its Legend Biotech (LEGN) stake by 338% in Q3 2026, buying an estimated $2.55M and bringing the position to 154,663 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #5365.

Jeff Yass first reported a position in LEGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $8.74M in Q2 2025. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Jeff Yass held 154,663 shares of Legend Biotech worth $3.08M as of Q3 2026.
  • Jeff Yass bought 119,315 Legend Biotech shares in Q3 2026, an estimated $2.55M.
  • Legend Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5365 holding.
  • Jeff Yass first reported a position in Legend Biotech in Q1 2021 and has held it in 18 quarters since.
  • Jeff Yass's Legend Biotech position peaked at $8.74M in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.